bruising at glp 1 injection site Delayed type hypersensitivity reaction and tolerance induction to liraglutide for the treatment of obesity Ozempic injection bruising and hematoma
Description
Exenatide (2005) and Liraglutide (2014) are both short-acting drugs
Its dual action on both GLP-1 and GIP receptors may offer advantages over medications that target these receptors individually, potentially providing better control of blood sugar levels and more effective weight management
Interestingly, the mean values remain relatively normal in most T2DM groups ( Shortly after food intake, these incretins are released into body circulation and bind to their receptors
While many common medications do not prevent donation, certain classes of drugs can lead to temporary or even permanent deferral
